Eagle Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,596
Closed -$1.88M 566
2023
Q2
$1.88M Sell
3,596
-3,349
-48% -$1.81M 0.01% 446
2023
Q1
$4M Sell
6,945
-3,753
-35% -$2.12M 0.02% 370
2022
Q4
$5.92M Sell
10,698
-2,655
-20% -$1.41M 0.04% 308
2022
Q3
$6.77M Sell
13,353
-272
-2% -$152K 0.04% 295
2022
Q2
$7.4M Sell
13,625
-500
-4% -$275K 0.05% 287
2022
Q1
$8.34M Sell
14,125
-1,517
-10% -$871K 0.04% 304
2021
Q4
$10.4M Buy
15,642
+406
+3% +$253K 0.05% 303
2021
Q3
$8.7M Buy
15,236
+2,564
+20% +$1.41M 0.04% 339
2021
Q2
$6.39M Sell
12,672
-8,274
-40% -$3.9M 0.03% 390
2021
Q1
$9.56M Buy
20,946
+20,142
+2,505% +$9.61M 0.04% 325
2020
Q4
$374K Sell
804
-19,613
-96% -$9.2M ﹤0.01% 480
2020
Q3
$8.87M Buy
20,417
+4,720
+30% +$1.95M 0.05% 299
2020
Q2
$5.51M Sell
15,697
-6,278
-29% -$2.1M 0.03% 363
2020
Q1
$6.23M Buy
21,975
+68
+0.3% +$21.4K 0.04% 338
2019
Q4
$7.12M Sell
21,907
-63
-0.3% -$19.1K 0.03% 357
2019
Q3
$6.4M Sell
21,970
-128
-0.6% -$36.7K 0.03% 369
2019
Q2
$6.49M Buy
22,098
+4,622
+26% +$1.27M 0.03% 374
2019
Q1
$4.78M Buy
17,476
+224
+1% +$55.7K 0.03% 416
2018
Q4
$3.86M Sell
17,252
-159
-0.9% -$37.3K 0.02% 421
2018
Q3
$4.25M Buy
17,411
+498
+3% +$115K 0.02% 450
2018
Q2
$3.5M Buy
16,913
+310
+2% +$65.8K 0.02% 464
2018
Q1
$3.43M Buy
16,603
+79
+0.5% +$16.6K 0.02% 473
2017
Q4
$3.43M Sell
16,524
-126
-0.8% -$24.1K 0.02% 478
2017
Q3
$3.19M Sell
16,650
-127
-0.8% -$23K 0.02% 488
2017
Q2
$2.93M Sell
16,777
-8
-0% -$1.34K 0.02% 493
2017
Q1
$2.58M Buy
16,785
+425
+3% +$65K 0.02% 526
2016
Q4
$2.31M Buy
+16,360
New +$2.41M 0.02% 534
2013
Q3
Sell
-36,494
Closed -$3.09M 709
2013
Q2
$3.09M Buy
+36,494
New +$3.04M 0.02% 546

Other funds holding TMO